De Novo device
Lumenis Stellar M22
Lumenis, Ltd. · Intense Pulsed Light Device For Managing Dry Eye (QIU, Class II) · First FDA decision Feb 23, 2021, newest Feb 23, 2021Dry eye
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
0
Naming "Stellar M22"
MAUDE reports
24
Brand "Stellar M22", since 2015
PubMed studies
0
Mentioning "Stellar M22"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Lumenis Stellar M22
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Lumenis Stellar M22New device typeDe Novo
DEN200028 · Decided Feb 23, 2021 · 309 days after receipt
Device type: Intense Pulsed Light Device For Managing Dry Eye (QIU) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Stellar M22", any status and sponsor, newest update first.
No registered device study names "Stellar M22".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Stellar M22", and for the whole product code for context.
This brand
24 reports: 0 malfunction, 24 injury, 0 death
Whole product code QIU
1 reports: 0 malfunction, 1 injury, 0 death
Newest reports for this brand
- Stellar M22Injury
3021349626-2026-00017 · Received Oct 28, 2026 · Event dated Sep 29, 2026
Device type: Powered Laser Surgical Instrument (GEX)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Burn(s); Insufficient Information
- Stellar M22Injury
3020611964-2026-00015 · Received Oct 28, 2026 · Event dated Sep 29, 2026
Device type: Powered Laser Surgical Instrument (GEX)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Burn(s)
- Stellar M22Injury
3021349626-2026-00015 · Received Oct 13, 2026 · Event dated Sep 16, 2026
Device type: Powered Laser Surgical Instrument (GEX)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Burn(s); Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Stellar M22"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.